NCT00335764 2018-07-02
Sorafenib Combined With Erlotinib, Tipifarnib, or Temsirolimus in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
National Cancer Institute (NCI)
Phase 1/2 Completed
Clinical Trials
3 trialsNCT00864032 2013-04-10
Trial of Neoadjuvant Conformal Radiotherapy Plus Sorafenib for Patients With Soft Tissue Sarcoma of the Extremity and Body Wall
University of California, Davis
Phase 1/2 Completed
NCT00541840 2008-05-12
Phase I-II Trial of Sorafenib in Combination With Ifosfamide in Soft Tissue Sarcoma
Grupo Espanol de Investigacion en Sarcomas
Phase 1/2 Unknown